Home > Insider Trading > Filing (0001209191-23-054907)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1907108	Lexeo Therapeutics Inc.	LXEO	()	G7

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591046	A/S Invest Lundbeckfond	Scherfigsvej 7 Copenhagen G7 DK-2100		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-11-07	1,321,474	$0.00	1,321,474	No	4	C	Direct
Common Stock	Acquisiton	2023-11-07	287,213	$0.00	1,608,687	No	4	C	Direct
Common Stock	Acquisiton	2023-11-07	227,272	$11.00	1,835,959	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A convertible preferred stock	Disposition	2023-11-07	13,999,999	$0.00	1,321,474	$0.00
Common Stock	Series B convertible preferred stock	Disposition	2023-11-07	2,615,533	$0.00	287,213	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date.
Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date.